NEW YORK, Feb. 7 - Orchid BioSciences and a unit of Thermo Electron have signed a series of technology agreements to develop and market SNP-based diagnostic tests for point-of-care applications and genotyping products for research.

Terms of the agreements call for Orchid to receive non-exclusive rights from Thermo Electron's Thermo BioStar business to develop, supply, and sell genotyping products that will combine Orchid's SNP-IT genotyping technology with BioStar's OIA biosensor technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.